Maintain ‘neutral’ for Jyothy Laboratories with TP of Rs 380

By: |
Published: January 19, 2018 2:45:43 AM

Reported power brand sales grew just 9.3% y-o-y. EBITDA rose 36.8% y-o-y to Rs 69.3 crore (est of Rs 61 crore). Adj PAT after non-controlling interest (NCI) grew 61.5% y-o-y to Rs 34.7 croe (est. of Rs 34.7 crore).

Jyothy Laboratories, EBITDA, Bihar, West Bengal, Wholesale trade, rural growth, Personal careFabric care, Dishwashing and Personal care grew 9%, 12.4% and 30.9%, respectively, while Household Insecticides fell 17.1% y-o-y. (Reuters)

Reported power brand sales grew just 9.3% y-o-y. EBITDA rose 36.8% y-o-y to Rs 69.3 crore (est of Rs 61 crore). Adj PAT after non-controlling interest (NCI) grew 61.5% y-o-y to Rs 34.7 croe (est. of Rs 34.7 crore). Fabric care, Dishwashing and Personal care grew 9%, 12.4% and 30.9%, respectively, while Household Insecticides fell 17.1% y-o-y. Other expenses declined by 80bp y-o-y, while staff costs and A&P rose 10bp and 50bp, respectively. Thus, consolidated EBITDA margin expanded 290bp y-o-y to 16.1%. (1) Management reiterated positive rural growth outlook stated by them in the 2QFY18 call. (2) Volume growth of 8-10% is sustainable for JYL, going forward. (3) Wholesale trade has largely stabilized; only some parts of UP, Bihar and West Bengal are seeing some wholesale trade pressure.

Changes to the model have not resulted in material changes in FY18/FY19/FY20E EPS. Pace of earnings growth (for FY17-20E) appears moderate for a company that is much smaller in terms of size compared to mid-cap peers. RoE is also at a discount to peers at 18% and 21.7% for FY19E and FY20E, respectively. Given these worries, valuation of 21.8x FY19E EV/ EBITDA and 33.8x FY19E EPS does not offer scope for a significant upside. Targeting 20x Dec’19E EV/ EBITDA (20% discount to staples peers’ average), we get a TP of Rs 380 (R375 earlier). Maintain ‘Neutral’.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.